Skip to Main Content

Author Details

Andrew D Campbell
Departments of Hematology at Children's National Hospital
1996
80
26
PMIDPaper TitleJournal TitlePublished Year
36698745Design of an adaptive randomized clinical trial of intravenous citrulline for sickle cell pain crisis in the emergency department.Contemp Clin Trials Commun2023
37458568Return visit rates after an emergency department discharge for children with sickle cell pain episodes.Pediatr Blood Cancer2023
37217303The evolution of the COVID-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron.Br J Haematol2023
36873869Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospital.Front Med (Lausanne)2023
35166851Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana.Pain Med2022
35451176Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years.Pediatr Blood Cancer2022
36030599Amino acid signature during sickle cell pain crisis shows significant alterations related to nitric oxide and energy metabolism.Mol Genet Metab2022
33401140Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort.Blood Cells Mol Dis2021
33838114Will the changing therapeutic landscape meet the needs of patients with sickle cell disease?Lancet Haematol2021
34530179Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke.Transplant Cell Ther2021
34548040Diagnosis patterns of sickle cell disease in Ghana: a secondary analysis.BMC Public Health2021
34564050Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort.Blood Cells Mol Dis2021
34002408Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.Transfusion2021
32131139Parvovirus B19 infection in sickle cell disease: An analysis from the Centers for Disease Control haemoglobinopathy blood surveillance project.Transfus Med2020
33323100Annual Academy of Sickle Cell and Thalassaemia (ASCAT) conference: a summary of the proceedings.BMC Proc2020
32972798Corrigendum to "Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease" [Hum. Immunol. (2016) 35-40].Hum Immunol2020
32597290The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.J Manag Care Spec Pharm2020
32706890Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia.Blood Adv2020
33021900The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.OMICS2020
32697331The CYB5R3<sup>c</sup> <sup>.350C&gt;G</sup> and G6PD A alleles modify severity of anemia in malaria and sickle cell disease.Am J Hematol2020
32243618Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.Am J Hematol2020
32170816Correlation of lipid peroxidation and nitric oxide metabolites, trace elements, and antioxidant enzymes in patients with sickle cell disease.J Clin Lab Anal2020
32377816A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.Ann Hematol2020
29411862A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis.Br J Haematol2019
31469310Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.Ann Am Thorac Soc2019
31117252Serum Iron Levels and Copper-to-Zinc Ratio in Sickle Cell Disease.Medicina (Kaunas)2019
30758856Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.Transfusion2019
28801954An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes.Pediatr Blood Cancer2018
30233199Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.Vasc Health Risk Manag2018
29954157Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients.Med Sci (Basel)2018
30577523Correlation Between Soluble Endothelial Adhesion Molecules and Nitric Oxide Metabolites in Sickle Cell Disease.Med Sci (Basel)2018
29455883Disseminated Intravascular Coagulation and Acute Liver Injury from Ethanol Embolization of an Arteriovenous Malformation.J Vasc Interv Radiol2018
27030515mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.Br J Haematol2016
26613837Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia.J Pediatr Surg2016
26476208Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.Hum Immunol2016
26372199Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease.Hemoglobin2016
26500093Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.Biol Blood Marrow Transplant2016
27354937Proceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell Disease.Appl Transl Genom2016
26771086The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β(0) -thalassaemia homozygotes.Br J Haematol2016
25382665Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry.Am J Hematol2015
26460253TR2/TR4 overexpression in a humanized sickle cell disease mouse model decreases RBC adhesion to VCAM-1.Blood Cells Mol Dis2015
26296885Intestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease.J Biol Chem2015
26161296Melanoma tumor growth is accelerated in a mouse model of sickle cell disease.Exp Hematol Oncol2015
26031919The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice.Blood2015
25561507Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genes.Blood2015
24361300Differences in the clinical and genotypic presentation of sickle cell disease around the world.Paediatr Respir Rev2014
24662048PGC-1 coactivator activity is required for murine erythropoiesis.Mol Cell Biol2014
24652968Increased stroke size following MCA occlusion in a mouse model of sickle cell disease.Blood2014
24309610Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia.J Pediatr Hematol Oncol2014
22903793Who counsels parents of newborns who are carriers of sickle cell anemia or cystic fibrosis?J Genet Couns2013
  • 1 - 50 of 80

Recommended Authors

Duke University School of Medicine
Career Start Year 2018
Number of shared co-authors 0
Cancer & Blood Diseases Institute, Cincinnati Children's Hospital Medical Center
Career Start Year 2015
Number of shared co-authors 1
Rainbow Babies and Children's Hospital
Career Start Year 2012
Number of shared co-authors 3
Duke University
Career Start Year 2011
Number of shared co-authors 6
Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 2
Christian Medical College
Career Start Year 2007
Number of shared co-authors 4
Texas Children's Hospital and Baylor College of Medicine
Career Start Year 2007
Number of shared co-authors 0
904th Hospital of Joint Logistic Support Force of PLA (Suzhou)
Career Start Year 2007
Number of shared co-authors 0
Center for Biologics Evaluation and Research
Career Start Year 2006
Number of shared co-authors 1
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 2005
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 2004
Number of shared co-authors 4
Brigham and Women's Hospital
Career Start Year 2004
Number of shared co-authors 0
University of Pittsburgh and University of Pittsburgh Medical Center
Career Start Year 2003
Number of shared co-authors 2
Liege University Hospital
Career Start Year 2003
Number of shared co-authors 2
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Career Start Year 2002
Number of shared co-authors 1
John R. Oishei Children's Hospital of Buffalo
Career Start Year 2002
Number of shared co-authors 2
Emory University School of Medicine
Career Start Year 2001
Number of shared co-authors 2
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Career Start Year 2000
Number of shared co-authors 4
Center for Sickle Cell Disease, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 6
Carver College of Medicine, University of Iowa
Career Start Year 1999
Number of shared co-authors 0
University Health Network
Career Start Year 1996
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 5
Penn State Hershey Children's Hospital
Career Start Year 1994
Number of shared co-authors 0
Hospital
Career Start Year 1992
Number of shared co-authors 0
17120University of Illinois College of Medicine peoria
Career Start Year 1992
Number of shared co-authors 2
Sainte Justine and Montreal Heart Institute, University of Montreal
Career Start Year 1990
Number of shared co-authors 2
University of Michigan ann arbor
Career Start Year 1981
Number of shared co-authors 0
University of Washington, Seattle Children's Hospital
Career Start Year 1981
Number of shared co-authors 0
Sainte Justine and Montreal Heart Institute, University of Montreal
Career Start Year 1979
Number of shared co-authors 2
Center for Blood Oxygen Transport and Hemostasis, University of Maryland
Career Start Year 1974
Number of shared co-authors 3

Collaborators

Co-authored papers 20
University of Maryland School of Medicine
Co-authored papers 16
Co-authored papers 14
Children's National Hospital
Co-authored papers 13
Evelina Children's Hospital, Guy's and St. Thomas NHS Foundation Trust
Co-authored papers 8
Tohoku University Graduate School of Medicine, Tohoku University
Co-authored papers 4
Center for Sickle Cell Disease, Howard University College of Medicine
Co-authored papers 4
Children's Research National Institute, Children's National Hospital
Co-authored papers 3
Co-authored papers 2
Universite de Strasbourg
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Vanderbilt University School of Medicine
Co-authored papers 2
Caribbean Institute for Health Research, The University of the West Indies
Co-authored papers 2
Loyola University Medical Center.
Co-authored papers 2
Unidade de Onco-Hematologia, Instituto da Crianca
Co-authored papers 2
London North West University Healthcare NHS Trust, Imperial College London
Co-authored papers 2
Makerere University College of Health Sciences
Co-authored papers 2
University of Cape Town
Co-authored papers 2
University of Cape Town
Co-authored papers 2
Co-authored papers 2
University Teaching Hospitals-Children's Hospital
Co-authored papers 2
University of Cape Town
Co-authored papers 2
University of Pittsburgh
Co-authored papers 2
University of Abuja (CESRTA) Federal Capital Territory (FCT)
Co-authored papers 2
Children's Hospital of Philadelphia
Co-authored papers 1
Boston University Chobanian & Avedisian School of Medicine
Co-authored papers 1
Co-authored papers 1
Institute of Endemic Diseases, University of Khartoum
Co-authored papers 1
Non-Communicable Diseases Research Unit, South African Medical Research Council
Co-authored papers 1
Co-authored papers 1